ArticleBioactive materials2027
Ultrasound-activated piezoelectric muscle constructs for tissue-engineered regenerative peripheral nerve interfaces.
Article in Bioactive materials, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Regenerative peripheral nerve interfaces (RPNIs) are emerging platforms capable to translate neural activity into controllable myoelectric signals. However, current clinical RPNIs rely on muscle autografts, limiting their scalability and extensive adoption. Here, we report a bioactive, ultrasound-responsive piezoelectric muscle biomaterial designed as a fully tissue-engineered alternative to autologous grafts. The construct consists of fibrinogen-based muscle tissues enriched with barium titanate nanoparticles (BTNPs, diameter∼60 nm) and supported by a biodegradable surgical membrane that promotes the formation of aligned, multinucleated myotubes. The incorporation of BTNPs imparts intrinsic piezoelectric activity to the construct, and the nanoparticles are taken up by developing myotubes, enabling remote mechanoelectrical tissue stimulation under low-intensity pulsed ultrasound (LIPUS). In vivo, piezoelectric constructs implanted around the rat peroneal nerve for two months undergo LIPUS-driven activation of internalized BTNPs, which enhances muscle maturation, and electromechanical responsiveness, yielding myoelectrical signals up to 3.2 mV upon nerve activation. Histological analyses confirm improved structural organization, increased desmin expression, and evidence of neovascularization and axonal regeneration within the engineered interface. These findings suggest that the piezoelectric constructs form stable, functional biointerfaces with peripheral nerves, and that LIPUS-driven activation of embedded BTNPs provides a non-invasive strategy to potentiate muscle development and signal transduction. This study positions LIPUS-responsive, engineered piezoelectric muscle constructs as a donor-free, bioactive platform alternative to traditional autografts for next-generation human-machine interfaces and regenerative bioelectronics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.